|
Summary Information: Viridian Therapeutics Inc. Common Stock NASDAQ:VRDN |
  [email protected] |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado , with research and development operations in Waltham, Massachusetts.
__The following are links to various summary and news pages for __Viridian Therapeutics Inc. Common Stock [ VRDN ]. __Note: Some Links might not have information for the company. |
|